首页> 美国卫生研究院文献>British Journal of Cancer >Stage-associated overexpression of the ubiquitin-like protein ISG15 in bladder cancer
【2h】

Stage-associated overexpression of the ubiquitin-like protein ISG15 in bladder cancer

机译:与阶段相关的泛素样蛋白ISG15在膀胱癌中的过表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bladder cancer is among the most prevalent malignancies, and is characterised by frequent tumour recurrences and localised inflammation, which may promote tissue invasion and metastasis. Microarray analysis was used to compare gene expression in normal bladder urothelium with that in tumours at different stages of progression. The innate immune response gene, interferon-stimulated gene 15 kDa (ISG15, GIP2), was highly expressed at all stages of bladder cancer as compared to normal urothelium. Western blotting revealed a tumour-associated expression of ISG15 protein. ISG15 exhibited a stage-associated expression, with significantly (P<0.05) higher levels of ISG15 protein in muscle-invasive T2–T4 tumours, compared with normal urothelium. Although ISG15 is involved in the primary immune response, ISG15 expression did not correlate with bladder inflammation. However, immunohistochemical staining revealed expression of ISG15 protein in both cancer cells and stromal immune cells. Interestingly, a significant fraction of ISG15 protein was localised to the nuclei of tumour cells, whereas no nuclear ISG15 staining was observed in ISG15-positive stromal cells. Taken together, our findings identify ISG15 as a novel component of bladder cancer-associated gene expression.
机译:膀胱癌是最普遍的恶性肿瘤之一,其特征是频繁的肿瘤复发和局部炎症,这可能会促进组织的侵袭和转移。微阵列分析用于比较正常膀胱尿路上皮与不同进展阶段肿瘤中的基因表达。与正常尿道上皮相比,先天性免疫应答基因,即干扰素刺激的基因15DakDa(ISG15,GIP2)在膀胱癌的所有阶段均高表达。蛋白质印迹显示ISG15蛋白与肿瘤相关的表达。与正常尿路上皮相比,ISG15表现出与阶段相关的表达,在肌肉浸润性T2-T4肿瘤中ISG15蛋白水平显着(P <0.05)。尽管ISG15参与了原发性免疫反应,但ISG15的表达与膀胱炎症无关。然而,免疫组织化学染色揭示了ISG15蛋白在癌细胞和基质免疫细胞中的表达。有趣的是,ISG15蛋白的很大一部分位于肿瘤细胞的核中,而在ISG15阳性基质细胞中未观察到核ISG15染色。综上所述,我们的发现将ISG15鉴定为膀胱癌相关基因表达的新组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号